IntelGenx Technologies Corp.
IGXTDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001098880
IntelGenx Technologies Corp. was delisted in 2024; its insiders filed their last Form 4 on May 3, 2024; 1 institution reported holding it in 13F filings for Q1 2024, worth $414 in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 1
- Q1 2024, +1 vs. previous quarter
- 13F value
- $414
- Reported value at the end of Q1 2024
- Superinvestors holding
- 0
- At the end of Q1 2024
Superinvestors holding IGXT, Q1 2024
No superinvestor reported holding IGXT at the end of Q1 2024.
Latest insider trades
Open-market purchases and sales by IntelGenx Technologies Corp. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 12, 2024 (view filing)9:36 PM ET | Nov 28, 2023 | 105 daysLate | ATAI Life Sciences AG and 1 other10% Owner | PPurchase | +8.11M | – | – | –16.1M after | Derivative2 lots |
| Sep 5, 2023 (view filing)9:00 PM ET | Aug 31 | 5 days | ATAI Life Sciences AG and 1 other10% Owner | PPurchase | +24.0M | – | – | –12.0M after | Derivative2 lots |
| Oct 3, 2022 (view filing)8:47 AM ET | Sep 30 | 3 days | Zerbe Horst GChief Executive Officer | PPurchaseCommon Stock, 0.00001 p.V | +19.0K | $0.1251 | +$2.38K | +5.4%368.1K after | 2 lots |
| Oct 3, 2022 (view filing)8:12 AM ET | Sep 29 | 4 days | Godin AndrePresident and CFO | PPurchaseCommon Stock, 0.00001 p.V. | +5.00K | $0.124 | +$620 | +1.6%308.4K after | |
| Sep 29, 2022 (view filing)8:01 AM ET | Sep 27-28 | 2 days | Godin AndrePresident and CFO | PPurchaseCommon Stock, 0.00001 p.V. | +10.0K | $0.1346 | +$1.35K | +3.4%303.4K after | 2 lots |
| Sep 28, 2022 (view filing)8:00 AM ET | Sep 26 | 2 days | Kenny TommyVP IP Legal Affairs-Subsidiary | PPurchaseCommon Stock, 0.00001 p.V. | +19.0K | $0.135 | +$2.56K | +15.9%138.5K after | |
| Sep 26, 2022 (view filing)8:27 AM ET | Sep 22 | 4 days | Kenny TommyVP IP Legal Affairs-Subsidiary | PPurchaseCommon Stock, 0.00001 p.V. | +23.5K | $0.145 | +$3.41K | +27.3%109.5K after | |
| Sep 26, 2022 (view filing)8:27 AM ET | Sep 22-23 | 4 days | Kenny TommyVP IP Legal Affairs-Subsidiary | PPurchaseCommon Stock, 0.00001 p.V | +10.0K | $0.1472 | +$1.47K | +9.1%119.5K after | 2 lots |
| Sep 22, 2022 (view filing)4:15 PM ET | Sep 21 | 1 day | Godin AndrePresident and CFO | PPurchaseCommon Stock, 0.00001 p.V | +20.0K | $0.134 | +$2.68K | +7.3%293.4K after | |
| Sep 22, 2022 (view filing)9:26 AM ET | Sep 21 | 1 day | Matzen DanaVP BD & Corp.Dev.of Subsidiary | PPurchaseCommon Stock, 0.00001 p.V. | +25.0K | $0.138 | +$3.45K | +50.0%75.0K after |
Top 10 13F holders, Q1 2024
The largest institutional positions in IntelGenx Technologies Corp. at the end of Q1 2024; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vima LLC | 2,300 | $414 | 0.00% | +2,300 | New |